Reply to: "The Impact of Donor Liver Fibrosis on Early Allograft Dysfunction and Ischemia-Reperfusion Injury."

Hirofumi HiraoTakahiro ItoJerzy W Kupiec-WeglinskiFady M Kaldas

Published in: Hepatology (Baltimore, Md.) (2021)

We thank Bekki et al. for their insightful comments on our published paper in Hepatology, in which we demonstrated the impact of donor occult fibrosis on liver transplant (LT) outcomes including ischemia reperfusion injury (IRI) and early allograft dysfunction (EAD).

Keyphrases

ischemia reperfusion injury
liver fibrosis
oxidative stress
randomized controlled trial
type diabetes
systematic review
metabolic syndrome
meta analyses